Your browser doesn't support javascript.
loading
Three-year Follow-up on the Safety and Effectiveness of Rituximab Plus Chemotherapy as First-Line Treatment of Diffuse Large B-Cell Lymphoma and Follicular Lymphoma in Real-World Clinical Settings in China: A Prospective, Multicenter, Noninterventional Study.
Wu, Jian-Qiu; Song, Yong-Ping; Su, Li-Ping; Zhang, Ming-Zhi; Li, Wei; Hu, Yu; Zhang, Xiao-Hong; Gao, Yu-Huan; Niu, Zuo-Xing; Feng, Ru; Wang, Wei; Peng, Jie-Wen; Li, Xiao-Lin; Ouyang, Xue-Nong; Wu, Chang-Ping; Zhang, Wei-Jing; Zeng, Yun; Xiao, Zhen; Liang, Ying-Min; Zhuang, Yong-Zhi; Wang, Ji-Shi; Sun, Zi-Min; Bai, Hai; Cui, Tong-Jian; Feng, Ji-Feng.
Afiliación
  • Wu JQ; Department of Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & Nanjing Medical University Affiliated Cancer Hospital, Nanjing, Jiangsu 210008, China.
  • Song YP; Department of Hematology, Henan Cancer Hospital, Zhengzhou, Henan 450000, China.
  • Su LP; Department of Hematology, Shanxi Cancer Hospital, Taiyuan, Shanxi 030013, China.
  • Zhang MZ; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450000, China.
  • Li W; Department of Oncology, Jilin University First Affiliated Hospital, Changchun, Jilin 130000, China.
  • Hu Y; Department of Hematology, Union Hospital Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430072, China.
  • Zhang XH; Department of Hematology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, China.
  • Gao YH; Department of Hematology, Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, China.
  • Niu ZX; Department of Oncology, Affiliated Hospital of Shandong Academy of Medical Sciences, Jinan, Shandong 250000, China.
  • Feng R; Department of Hematology, Medical University Nanfang Hospital, Guangzhou, Guangdong 510000, China.
  • Wang W; Department of Oncology, Guangdong Foshan First Hospital, Foshan, Guangdong 528000, China.
  • Peng JW; Department of Oncology, Guangdong Zhongshan People's Hospital, Zhongshan, Guangdong 528403, China.
  • Li XL; Department of Hematology, Xiangya Hospital Central South University, Changsha, Hunan 410008, China.
  • Ouyang XN; Department of Oncology, Fuzhou General Hospital of Nanjing Military Command, Fuzhou, Fujian 350001, China.
  • Wu CP; Department of Oncology, Changzhou First People's Hospital, Changzhou, Jiangsu 213000, China.
  • Zhang WJ; Department of Oncology, 307 Hospital of Chinese People's Liberation Army, Beijing 100070, China.
  • Zeng Y; Department of Hematology, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650221, China.
  • Xiao Z; Department of Hematology, Affiliated Hospital of Neimenggu Medical College, Hohhot, Huhehaote, Inner Mongolia 010050, China.
  • Liang YM; Department of Hematology, The Fourth Military Medical University Affiliated Tangdu Hospital, Xi'an, Shaanxi 710038, China.
  • Zhuang YZ; Department of Oncology, Daqing General Hospital Group Oilfield General Hospital, Daqing, Heilongjiang 163001, China.
  • Wang JS; Department of Hematology, Affiliated Hospital of Guiyang Medical College, Guiyang, Guizhou 550004, China.
  • Sun ZM; Department of Hematology, Anhui Provincial Hospital, Hefei, Anhui 23000, China.
  • Bai H; Department of Hematology, Lanzhou Military Hospital, Lanzhou, Gansu 730046, China.
  • Cui TJ; Department of Oncology, Fujian Provincial Hospital, Fuzhou, Fujian 350001, China.
  • Feng JF; Department of Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & Nanjing Medical University Affiliated Cancer Hospital, Nanjing, Jiangsu 210008, China.
Chin Med J (Engl) ; 131(15): 1767-1775, 2018 Aug 05.
Article en En | MEDLINE | ID: mdl-30058572
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Folicular / Linfoma de Células B Grandes Difuso / Rituximab Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Chin Med J (Engl) Año: 2018 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Folicular / Linfoma de Células B Grandes Difuso / Rituximab Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Chin Med J (Engl) Año: 2018 Tipo del documento: Article País de afiliación: China